Funder
Department of Biotechnology, Ministry of Science and Technology
Council of Scientific and Industrial Research, India
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference28 articles.
1. Bansal R, Dash R, Rathore AS. Impact of mAb aggregation on its biological activity: rituximab as a case study. J Pharm Sci. 2020;109(9):2684–98.
2. Joubert MK, Luo Q, Nashed-Samuel Y, Wypych J, Narhi LO. Classification and characterization of therapeutic antibody aggregates. J Biol Chem. 2011;286(28):25118–33.
3. Rosenberg AS, Sauna ZE. Immunogenicity assessment during the development of protein therapeutics. J Pharm Pharmacol. 2018;70(5):584–94.
4. ICH harmonised tripartite guideline, specifications: test procedures and acceptance criteria for biotechnological/biological products Q6B; 1999. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-6-b-test-procedures-acceptance-criteria-biotechnological/biological-products-step-5_en.pdf. Accessed 25 March 2021.
5. Narhi LO, Schmit J, Bechtold-Peters K, Sharma D. Classification of protein aggregates. J Pharm Sci. 2012;101(2):493–8.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献